HSP90 inhibitors stimulate DNAJB4 protein expression through a mechanism involving N<sup>6</sup>-methyladenosine.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31399576.
- Also identified by DOI 10.1038/s41467-019-11552-8 and PMC identifier 6688989.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Small-molecule inhibitors for the 90-kDa heat shock protein (HSP90) have been extensively exploited in preclinical studies for the therapeutic interventions of human diseases accompanied with proteotoxic stress. By using an unbiased quantitative proteomic method, we uncover that treatment with three HSP90 inhibitors results in elevated expression of a large number of heat shock proteins. We also demonstrate that the HSP90 inhibitor-mediated increase in expression of DNAJB4 protein occurs partly through an epitranscriptomic mechanism, and is substantially modulated by the writer, eraser, and reader proteins of N<sup>6</sup>-methyladenosine (m<sup>6</sup>A). Furthermore, exposure to ganetespib leads to elevated modification levels at m<sup>6</sup>A motif sites in the 5'-UTR of DNAJB4 mRNA, and the methylation at adenosine 114 site in the 5'-UTR promotes the translation of the reporter gene mRNA. This m<sup>6</sup>A-mediated mechanism is also at play upon heat shock treatment. Cumulatively, we unveil that HSP90 inhibitors stimulate the translation of DNAJB4 through an epitranscriptomic mechanism.
Medical subject headings
- Adenosine
- HSP40 Heat-Shock Proteins
- HSP90 Heat-Shock Proteins
- Proteomics